Published in
Elsevier, European Urology Oncology, 2(5), p. 195-202, 2022
DOI: 10.1016/j.euo.2021.12.006
Links
Tools
A Phase 1/2 Single-arm Clinical Trial of Recombinant Bacillus Calmette-Guérin (BCG) VPM1002BC Immunotherapy in Non–muscle-invasive Bladder Cancer Recurrence After Conventional BCG Therapy: SAKK 06/14
Journal article published in 2022 by
Cyrill A. Rentsch,
George N. Thalmann,
Ilaria Lucca,
Maciej Kwiatkowski,
Grégory J. Wirth,
Räto T. Strebel,
Daniel Engeler 
,
Augusto Pedrazzini,
Clemens Hüttenbrink,
Wolfgang Schultze-Seemann,
Raimund Torpai,
Lukas Bubendorf,
Andreas Wicki ,
Beat Roth,
Heike Püschel
and other authors.
,
Augusto Pedrazzini,
Clemens Hüttenbrink,
Wolfgang Schultze-Seemann,
Raimund Torpai,
Lukas Bubendorf,
Andreas Wicki ,
Beat Roth,
Heike Püschel
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 